Catalytic Nanoceria Are Preferentially Retained in the Rat Retina and Are Not Cytotoxic after Intravitreal Injection

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Wong, Lily L ^a   Hirst, Suzanne M ^b   Pye, Quentin N ^a   Reilly, Christopher M ^b   Seal, Sudipta ^c   McGinnis, James F ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CENTRAL FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERIUM OXIDE NANOPARTICLE; NANOPARTICLE; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATALYSIS; CHRONIC TOXICITY; CYTOARCHITECTURE; CYTOTOXICITY; IN VIVO STUDY; LENS; LONG TERM EXPOSURE; MASS SPECTROMETRY; NONHUMAN; RAT; RETINA; RETINA CELL; RETINA ROD; RETINAL THICKNESS; VISUAL SYSTEM FUNCTION;

ANIMALS; CATALYSIS; CERIUM; ELECTRORETINOGRAPHY; FREE RADICAL SCAVENGERS; INTRAVITREAL INJECTIONS; NANOPARTICLES; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; RETINA; TISSUE DISTRIBUTION;

EID: 84874852947     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058431     Document Type: Article

References (41)

1. Thomas DG, Klaessig F, Harper SL, Fritts M, Hoover MD, et al. (2011) Informatics and standards for nanomedicine technology. Wiley Interdiscip Rev Nanomed Nanobiotechnol.
2. Karakoti A, Singh S, Dowding JM, Seal S, Self WT, (2010) Redox-active radical scavenging nanomaterials. Chem Soc Rev 39: 4422-4432.
3. McGinnis JF, Chen J, Wong L, Sezate S, Seal S, et al. (2010) Inhibition of reactive oxygen species and protection of mammalian cells. US Patent 7727559.
4. McGinnis JF, Chen J, Wong L, Sezate S, Seal S, et al. (2008) Inhibition of reactive oxygen species and protection of mammalian cells. US Patent 7347987.
5. Campbell CT, Peden CH, (2005) Chemistry. Oxygen vacancies and catalysis on ceria surfaces. Science 309: 713-714.
6. Inerbaev TM, Seal S, Masunov AE, (2010) Density functional study of oxygen vacancy formation and spin density distribution in octahedral ceria nanoparticles. J Mol Model 16: 1617-1623.
7. Korsvik C, Patil S, Seal S, Self WT (2007) Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles. Chem Commun (Camb): 1056-1058.
8. Pirmohamed T, Dowding JM, Singh S, Wasserman B, Heckert E, et al. (2010) Nanoceria exhibit redox state-dependent catalase mimetic activity. Chem Commun (Camb) 46: 2736-2738.
9. Self WT, Seal S (2009) Nanoparticles of cerium oxide having superoxide dismutase activity. US Patent 7504356.
10. Onyango IG, Khan SM, (2006) Oxidative stress, mitochondrial dysfunction, and stress signaling in Alzheimer's disease. Curr Alzheimer Res 3: 339-349.
11. Burn DJ, (2006) Cortical Lewy body disease and Parkinson's disease dementia. Curr Opin Neurol 19: 572-579.
12. Hogg R, Chakravarthy U, (2004) AMD and micronutrient antioxidants. Curr Eye Res 29: 387-401.
13. Hollyfield JG, (2010) Age-related macular degeneration: the molecular link between oxidative damage, tissue-specific inflammation and outer retinal disease: the Proctor lecture. Invest Ophthalmol Vis Sci 51: 1275-1281.
14. Madsen-Bouterse SA, Mohammad G, Kanwar M, Kowluru RA, (2010) Role of mitochondrial DNA damage in the development of diabetic retinopathy, and the metabolic memory phenomenon associated with its progression. Antioxid Redox Signal 13: 797-805.
15. Bhatti MT, (2006) Retinitis pigmentosa, pigmentary retinopathies, and neurologic diseases. Curr Neurol Neurosci Rep 6: 403-413.
16. Hartong DT, Berson EL, Dryja TP, (2006) Retinitis pigmentosa. Lancet 368: 1795-1809.
17. Chen J, Patil S, Seal S, McGinnis JF, (2006) Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides. Nat Nanotechnol 1: 142-150.
18. Zhou X, Wong LL, Karakoti AS, Seal S, McGinnis JF, (2011) Nanoceria Inhibit the Development and Promote the Regression of Pathologic Retinal Neovascularization in the Vldlr Knockout Mouse. PLoS ONE 6: e16733.
19. Kong L, Cai X, Zhou X, Wong LL, Karakoti AS, et al. (2011) Nanoceria extend photoreceptor cell lifespan in tubby mice by modulation of apoptosis/survival signaling pathways. Neurobiol Dis 42: 514-523.
20. Hirst SM, Karakoti AS, Tyler RD, Sriranganathan N, Seal S, et al. (2009) Anti-inflammatory Properties of Cerium Oxide Nanoparticles. Small 5: 2848-2856.
21. Celardo I, De Nicola M, Mandoli C, Pedersen JZ, Traversa E, et al. (2011) Ce(3)+ ions determine redox-dependent anti-apoptotic effect of cerium oxide nanoparticles. ACS Nano 5: 4537-4549.
22. Celardo I, Pedersen JZ, Traversa E, Ghibelli L, (2011) Pharmacological potential of cerium oxide nanoparticles. Nanoscale 3: 1411-1420.
23. Karakoti AS, Monteiro-Riviere NA, Aggarwal R, Davis JP, Narayan RJ, et al. (2008) Nanoceria as Antioxidant: Synthesis and Biomedical Applications. JOM (1989) 60: 33-37.
24. Pinilla I, Lund RD, Sauve Y, (2004) Contribution of rod and cone pathways to the dark-adapted electroretinogram (ERG) b-wave following retinal degeneration in RCS rats. Vision Res 44: 2467-2474.
25. Sauve Y, Pinilla I, Lund RD, (2006) Partial preservation of rod and cone ERG function following subretinal injection of ARPE-19 cells in RCS rats. Vision Res 46: 1459-1472.
26. Perlman I (2011) The Electroretinogram: ERG. In: Kolb H, editor. Webvision: The Organization of the Retina and Visual System. Salt Lake City, Utah, USA: University of Utah. Online Textbook of the Visual System.
27. Vincent A, Inerbaev TM, Babu S, Karakoti AS, Self WT, et al. (2010) Tuning hydrated nanoceria surfaces: experimental/theoretical investigations of ion exchange and implications in organic and inorganic interactions. Langmuir 26: 7188-7198.
28. Jeon CJ, Strettoi E, Masland RH, (1998) The major cell populations of the mouse retina. J Neurosci 18: 8936-8946.
29. Masland RH, (2011) Cell populations of the retina: the Proctor lecture. Invest Ophthalmol Vis Sci 52: 4581-4591.
30. Bazan NG, (2003) Synaptic lipid signaling. Journal of Lipid Research 44: 2221-2233.
31. Hirst SM, Karakoti A, Singh S, Self W, Tyler R, et al. (2011) Bio-distribution and in vivo antioxidant effects of cerium oxide nanoparticles in mice. Environmental Toxicology: N/a-n/a.
32. Singh S, Kumar A, Karakoti A, Seal S, Self WT, (2010) Unveiling the mechanism of uptake and sub-cellular distribution of cerium oxide nanoparticles. Mol Biosyst 6: 1813-1820.
33. Das M, Patil S, Bhargava N, Kang JF, Riedel LM, et al. (2007) Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. Biomaterials 28: 1918-1925.
34. Verma A, Stellacci F, (2010) Effect of Surface Properties on Nanoparticle-Cell Interactions. Small 6: 12-21.
35. Murdock RC, Braydich-Stolle L, Schrand AM, Schlager JJ, Hussain SM, (2008) Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol Sci 101: 239-253.
36. Asati A, Santra S, Kaittanis C, Perez JM, (2010) Surface-charge-dependent cell localization and cytotoxicity of cerium oxide nanoparticles. ACS Nano 4: 5321-5331.
37. Kim H, Robinson SB, Csaky KG, (2009) Investigating the movement of intravitreal human serum albumin nanoparticles in the vitreous and retina. Pharm Res 26: 329-337.
38. Kleinberg TT, Tzekov RT, Stein L, Ravi N, Kaushal S, (2011) Vitreous Substitutes: A Comprehensive Review. Survey of Ophthalmology 56: 300-323.
39. Patil S, Sandberg A, Heckert E, Self W, Seal S, (2007) Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential. Biomaterials 28: 4600-4607.
40. Van Bockxmeer FM, Martin CE, Constable IJ, (1983) Iron-binding proteins in vitreous humour. Biochim Biophys Acta 758: 17-23.
41. Vincent A, Babu S, Heckert E, Dowding J, Hirst SM, et al. (2009) Protonated Nanoparticle Surface Governing Ligand Tethering and Cellular Targeting. ACS Nano 3: 1203-1211.